Results 1 to 10 of about 92,170 (296)

AIM/CD5L attenuates DAMPs in the injured brain and thereby ameliorates ischemic stroke

open access: yesCell Reports, 2021
Summary: The sterile inflammation caused by damage-associated molecular patterns (DAMPs) worsens the prognosis following primary injury such as ischemic stroke. However, there are no effective treatments to regulate DAMPs.
Kaori Taniguchi   +2 more
exaly   +3 more sources

DAMPs and radiation injury

open access: yesFrontiers in Immunology
The heightened risk of ionizing radiation exposure, stemming from radiation accidents and potential acts of terrorism, has spurred growing interests in devising effective countermeasures against radiation injury.
Monowar Aziz, Max Brenner
exaly   +3 more sources

DAMPs prognostic signature predicts tumor immunotherapy, and identifies immunosuppressive mechanism of pannexin 1 channels in pancreatic ductal adenocarcinoma

open access: yesFrontiers in Immunology
BackgroundDamage-associated molecular patterns (DAMPs) induced by immunogenic cell death (ICD) may be useful for the immunotherapy to patients undergoing pancreatic ductal adenocarcinoma (PDAC).
Qianxue Wu, Liuying Li, Daqiang Song
exaly   +3 more sources

From stress signals to fertility challenges: the role of damage-associated molecular patterns in male reproduction [PDF]

open access: yesFrontiers in Immunology
Male infertility is influenced by genetic abnormalities, hormonal imbalances, lifestyle factors, and environmental exposures. Recently, Damage-Associated Molecular Patterns (DAMPs) have emerged as key players in male reproductive health, particularly in ...
Heran Cao   +10 more
doaj   +2 more sources

Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy [PDF]

open access: yesBioImpacts, 2023
Introduction: Silibinin is a natural flavonoid compound known to induce apoptosis in cancer cells. Despite silibinin's safety and efficacy as an anticancer drug, its effects on inducing immunogenic cell death (ICD) are largely unknown.
Sevda Jafari   +4 more
doaj   +1 more source

Can High Mobility Group Box 1 Protein Predict Ongoing Subclinical Inflammation in Patients With Familial Mediterranean Fever?

open access: yesJournal of Behçet Uz Children's Hospital, 2023
Objective: Familial Mediterranean fever (FMF) is an autoinflammatory disease that commonly presents with fever, peritonitis, and pleuritis. Recent studies have reported ongoing inflammation in the attack-free period of patients with FMF.
Betül Öztürk   +5 more
doaj   +1 more source

DAMP-mediated inflammation and regulated cell death in immunoinflammatory rheumatic diseases

open access: yesМедицинская иммунология, 2023
The state of autoreactivity of innate immunity dominates in the pathogenesis of immunoinflammatory rheumatic diseases,  inducing non-infectious “sterile” inflammation.
M. Z. Saidov
doaj   +1 more source

Using PAMPs and DAMPs as adjuvants in cancer vaccines

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Immunotherapy for cancer has attracted considerable attention. As one of the immunotherapeutics, tumor vaccines exert great potential for cancer immunotherapy.
Huanyou Sun   +10 more
doaj   +1 more source

Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy

open access: yesFrontiers in Oncology, 2022
ObjectivesTriple-negative breast cancer (TNBC) is defined as a highly aggressive type of breast cancer which lacks specific biomarkers and drug targets.
Ming Xu   +7 more
doaj   +1 more source

Tumor-related HSP70 released after cryo-thermal therapy targeted innate immune initiation in the antitumor immune response

open access: yesInternational Journal of Hyperthermia, 2020
Purpose In our previous study, a novel cryo-thermal therapy that could stimulate the maturation of innate immune cells to subsequently activate the CD4+Th1 cell-dominated antitumor response was developed.
Jun Zhu, Yue Lou, Ping Liu, Lisa X. Xu
doaj   +1 more source

Home - About - Disclaimer - Privacy